NFKB1 and chronic obstructive pulmonary disease: As shown in Fig. 6, our research confirms that the activation of circular pathway and continuous activation of NF-κB caused by the decrease of ICL in lung tissue and cells of COPD patients should promote carcinogenesis and tumor progression in COPD patients.